Overview
- 80 inspections across 62 sites are on record.
- 173 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-12.
At a glance
Inspections
80
Sites
62
Observations
173
Career since
Jun 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lilly del Caribe, Inc. | 12 May 2026 | Human Drugs | |
| KBI Biopharma, Inc. | 1 Apr 2026 | Human Drugs | On file |
| Janssen Cilag Manufacturing LLC | 11 Feb 2026 | Human Drugs | On file |
| Brisas Del Caribe Corp | 23 Jan 2026 | Animal Drugs & Feeds | On file |
| AIAC International Pharma, LLC | 7 Nov 2025 | Human Drugs | On file |
Sites inspected
Lilly del Caribe, Inc.Carolina, United States1 insp.
KBI Biopharma, Inc.Durham, United States1 insp.
Janssen Cilag Manufacturing LLCGurabo, United States1 insp.
Brisas Del Caribe CorpCanovanas, United States1 insp.
AIAC International Pharma, LLCArecibo, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Alan A Rivera10 shared
Jose F Velez9 shared
Angelica M Hernandez7 shared
Jose E Melendez5 shared
Yoriann M Cabrera Bartolomei4 shared
Vilmary Negron Rodriguez4 shared
Christian F Gomez Lugo3 shared
Mabany Lizardi3 shared
Ivis L Negron Torres3 shared
Damaris Y Hernandez2 shared
Full investigator report
Get the verbatim findings behind Marian E Ramirez's 173 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site